Liver cirrhosis is one of the most important public health issues in China. The etiological treatment for patients with decompensated liver cirrhosis to delay progression has always been the practical and effective classical strategy. High- quality or creative methods for diagnosis and treatment come from ordinary and careful work. Portal hypertension is in nature a vascular disease,and relief of pressure in the portal system in time is the key to prevention of disease progression and various severe complications. The therapeutic decision should be made on the basis of a comprehensive understanding of portal hypertension,and minimally invasive techniques are important methods for such strategies.
[1]YAO Z,YAO ZG,WANG Y,et al.Clinico-epidemiological analysis on liver cirrhosis[J].J Clin Hepatol,2001,17(1):38-40.(in Chinese)姚桢,姚宗歌,汪耘,等.肝硬化的临床流行病学分析[J].临床肝胆病杂志,2001,17(1):38-40.
|
[2]TANG CW.Liver cirrhosis[M]//GE JB.Internal Medicine.8th ed.Beijing:People's Medical Publishing House,2013:448-453.(in Chinese)唐承薇.肝硬化[M]//葛均波.内科学.第8版.北京:人民卫生出版社,2013:448-453.
|
[3]European Association for The Study of The Liver.EASL clinical practice guidelines:management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.
|
[4]SHAH NL,BANAEI YP,HOJNOWSKI KL,et al.Management options in decompensated cirrhosis[J].Hepat Med,2015,7:43-50.
|
[5] de FRANCHIS R,BavenoⅥFaculty.Expanding consensus in portal hypertension:report of the BavenoⅥConsensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol,2015,63(3):743-752.
|